Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-22T07:52:45.648Z Has data issue: false hasContentIssue false

Lithium: evidence reconsidered

Published online by Cambridge University Press:  03 January 2018

M Bernadt
Affiliation:
Department of Psychological Medicine, Kings School of Medicine and Dentistry, 103 Denmark Hill, London SE5 8AZ
G. Stein
Affiliation:
Department of Psychological Medicine, Kings School of Medicine and Dentistry, 103 Denmark Hill, London SE5 8AZ
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Dinan, T. G. & Barry, S. (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic non-responders. Acta Psychiatrica Scandinavica, 80, 97100.CrossRefGoogle Scholar
Katona, C. L. E., Abou-Saleh, M. T., Harrison, D. A., et al (1995) Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. British Journal of Psychiatry, 166, 8086.CrossRefGoogle ScholarPubMed
Moncrieff, J. (1997) Lithium: evidence reconsidered. British Journal of Psychiatry, 171, 113119.CrossRefGoogle ScholarPubMed
Stein, G. & Bernadt, M. (1988) Double blind trial of lithium carbonate in tricyclic resistant depression. In Lithium: Inorganic Pharmacology and Psychiatric Use (ed. Birch, N. J.). Oxford: IRL Press.Google Scholar
Stein, G. & Bernadt, M. (1993) Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. British Journal of Psychiatry, 162, 634640.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.